argenx to Announce H1 2024 Financials and Q2 Update on July 25, 2024

On July 18, 2024, Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a leading global immunology company, announced plans to host a conference call and audio webcast on Thursday, July 25, 2024, at 2:30 PM CET (8:30 AM ET). The purpose of this event is to discuss the company's financial results for the first half of 2024 and provide updates on their business activities during the second quarter.

The live webcast of the conference call will be accessible via the Investors section of argenx's website at argenx.com/investors. Additionally, a replay of the webcast will be available on the website for approximately one year following the presentation.

To ensure comprehensive participation, argenx has provided multiple dial-in numbers for different countries. The access code for the call is 3810049, and participants are encouraged to dial in 15 minutes prior to the scheduled start time.

argenx is a pioneering global immunology company with a steadfast commitment to improving the lives of individuals suffering from severe autoimmune diseases. The company collaborates with top academic researchers through its Immunology Innovation Program (IIP), aiming to convert immunology breakthroughs into a robust portfolio of innovative antibody-based medicines.

Among its notable achievements, argenx has successfully developed and commercialized the first approved neonatal Fc receptor (FcRn) blocker. This treatment is available in the U.S., Japan, Israel, the EU, the UK, Canada, and China, marking a significant milestone in the field of autoimmune disease therapy.

Furthermore, the company is conducting extensive evaluations of efgartigimod, a promising therapeutic candidate, across multiple severe autoimmune diseases. In addition to this, argenx is also advancing several early-stage experimental medicines within its therapeutic franchises, showcasing its dedication to expanding treatment options for autoimmune conditions.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!